Correlation Between Puma Biotechnology and OKYO Pharma

Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Puma Biotechnology and OKYO Pharma Ltd, you can compare the effects of market volatilities on Puma Biotechnology and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and OKYO Pharma.

Diversification Opportunities for Puma Biotechnology and OKYO Pharma

0.25

Correlation Coefficient

Puma Biotechnology  OKYO Pharma

Modest diversification

The 3 months correlation between Puma and OKYO is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and OKYO Pharma go up and down completely randomly.

Pair Corralation between Puma Biotechnology and OKYO Pharma

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.06 times more return on investment than OKYO Pharma. However, Puma Biotechnology is 1.06 times more volatile than OKYO Pharma Ltd. It trades about 0.07 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.02 per unit of risk. If you would invest  252.00  in Puma Biotechnology on September 16, 2024 and sell it today you would earn a total of  36.00  from holding Puma Biotechnology or generate 14.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Puma Biotechnology  vs.  OKYO Pharma Ltd

Puma Biotechnology

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

OKYO Pharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in OKYO Pharma Ltd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, OKYO Pharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Puma Biotechnology and OKYO Pharma

The main advantage of trading using opposite Puma Biotechnology and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.

The idea behind Puma Biotechnology and OKYO Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.